Treatment planning in implant dentistry - Colloquium

WEDNESDAY
THURSDAY
FRIDAY
SATURDAY
Friday, 14 th October
Afternoon
Friday, 14 th October
Afternoon
Friday, 14 th October
Afternoon
BTI : Biotechnology institute
NOBEL BIOCARE
ZIMMER DENTAL
A biological approach to implantology:
Atrophic maxilla treatment with
minimum invasive clinical techniques
using plasma rich in growth factors
(P.R.G.F®-ENDORET®)
Speakers:
Dr. Eduardo Anitua, Spain
Patient wellness has always been the goal
of every doctor doing implants. Quicker soft
tissue healing, lower pain and inflammation
levels, BIC increase on implants, shorter
osseointegration times, etc. are the drivers
and expectations. Dr. Eduardo Anitua has
spent the last 25 years doing implantology,
doing research and giving lectures about
how to develop the less invasive surgical
protocols focussed on patients. During his
professional life he has been developing
the use of growth factor as a key tool to
establish safe, repeatable and predictable
surgical protocols when facing the most
delicate clinical indications: narrow crest,
lack of vertical bone, sinus lift techniques,
etc.
Dr. Eduardo Anitua during his lecture will
have a review of his surgical protocols
and will show long term follow up results
to confirm the predictability of those
protocols and the low invasive level of them.
In summary he will describe his biologically
guided implantology.
Dr. Gorka Orive, Spain
Dr. Orive will have a review about the last 15
years of research on plasma rich in growth
factors (P.R.G.F®-ENDORET®). He will
detail several aspects linked to this cutting
edge technique: protocol to obtain the four
different formulations, preclinical data,
clinical studies, clinical results and scientific
publications. He will explain on detail the
biologic concepts supporting this technique
and why patients own proteins are meant to
be the best available biomaterial.
Dr. Konstantinos Mantalenakis, Greece
Dr. Konstantinos Mantalenakis will show his
personal experience when applying these
low invasive protocols described before.
Preferred Treatment Concepts for
Today’s Patient needs
Treatment planning of any implant case requires
proper diagnosis based on conventional and/or
digital technologies. The clinician’s goal is to serve
the patient by reducing the number of treatment
steps and by selecting the least invasive treatment
options as supported by the most relevant science.
Well-executed treatment planning will offer the
patient an effective and reliable result, improving
his/her quality of life.
This interactive treatment planning session will
be conducted by seven experienced clinicians,
researchers, presenters ;
Dr Aris Tripodakis, Dr Luc Vrielink, Dr Eirik
Salvesen, Dr Eric Van Dooren, Dr Mauro Fradeani
and Dr Christian Coachman
under the lead of the moderator Dr Bernard Touati
Session topics to be adressed and discussed by
the experts:
Treatment planning that focuses on surgical
considerations and procedures for advanced
residual ridge reduction in edentulous patients.
Treatment strategies and related protocols in
implant dentistry for edentulous patients have
changed dramatically and are being continually
refined and developed. The aim of this treatment
planning session is to focus on the specific
needs of the edentulous patient and the selected
management rationale for each specific case.
Treatment planning for anterior partial edentulism
with special emphasis on peri-implant soft tissue
management considerations as well as final
restorative options to provide long-lasting esthetic
results.
The aim of this treatment planning session is
to identify and optimally control those factors
that contribute to overall soft tissue health and
stability in dental implant treatment. These
factors include implant design, abutment type and
shape, restoration contour and a meticulously
and scrupulously executed sequence of clinical
procedures.
A knowledge of, and appreciation for esthetic,
biocompatible and functional parameters needs
to be combined with precision of fit objectives
and CAD/CAM technology to ensure optimal and
routine treatment outcomes. The aim of this part
of the treatment planning session is to identify
those factors that contribute to long-lasting and
esthetic results.
Diagnostic, treatment planning through digital
dentistry:
Could new developments and features in CAD/CAM
dentistry improve communication within the dental
team and influence even more reliable treatment
outcomes in restorative driven treatments?
distributor.markets@nobelbiocare.com
Osseoincorporation with Trabecular
Metal Implants.
The best thing next to bone.
Implant technology has significantly evolved
during the last year, addressing most of the
challenges for a better osseointegration and
increasing the predictability of the treatments.
But still some limitations remain and new
challenges need a response, have we reached
the limit of the current technologies? Which
is the next step for the future? Conventional
textured or coated implant surfaces achieve
bone-to-implant contact, or ongrowth.
What if in addition to osseointegration, we
could achieve Osseoincorporation? Trabecular
Metal Technology is an innovative material
designed for both ongrowth and ingrowth, or
osseoincorporation.
Prof. Dr. Markus Hürzeler, Germany
Implant developments over the last 20
years – successes and shortfalls.
Prof. Dr. Markus Hürzeler will review the
major developments in the technology of
dental implants over the last 20 years. He
will reflect on the most critical milestones
and assess their effects on enhanced
treatment options and patient outcome.
Michael Collins, Vice President of Research,
Development and Education, Zimmer Dental,
USA
Trabecular Metal Implant: Research and
development
Michael Collins will give an overview of the
research and development concept behind
the new Trabecular Metal Dental Implant.
An overview will be given on material
properties, design rationale and the status
and future plans of mechanical, animal and
human trial programmes will be presented.
Dr. Markus Schlee, Germany
Clinical Experience with Trabecular Metal
Implants
Dr. Markus Schlee was the first dentist
using the Trabecular Metal Dental Implant
clinically in Europe. He conducted two
studies on Trabecular Metal implants
(early loading study and a noninterventional
study). Moreover current concepts of
better soft and hard tissue integration of
dental implants will be discussed. Based
on the material properties combined with
optimized clinical procedures he will give
an overview of his clinical experience and
further possibilities with Trabecular Metal
implants.
13